Ningshao Xia

This paper develops a rapid de novo sequencing workflow for COVID-19 neutralizing antibodies, achieving high accuracy in mixed antibody mixtures.

This paper introduces Fusion, a de novo assembler for antibody sequences, demonstrating high accuracy in reconstructing monoclonal and mixed antibody sequences from mass spectrometry data.

The paper characterizes an early prefusion conformation of the SARS-CoV-2 Spike protein using cryo-EM and shows it forms a homotrimer with significant glycosylation.